Equinox Gold Corp (EQX)
Toronto Exchange · Canada · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 15.65 |
|---|---|
| 52-week range | 11.89 – 25.76 |
| Return, 1 month / 3 months | −8.4% / +29.6% |
| Return, 1 year / 3 years | −12.2% / +161.0% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 62.2% |
| Worst drawdown (1 year) | -52.7% |
| Average daily value traded | 68.96M CAD |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Equinox Gold Corp is a gold mining company based in Canada that operates mines across the Americas. It produces gold doré and concentrate from open-pit and underground operations, with assets in Brazil, the United States and Mexico. The company supplies gold to refiners and precious metals markets, and it also explores for and develops mineral properties. Its activities span mining, processing and the continued development of its project pipeline in the regions where it operates.
The shares are listed on the Toronto Exchange in Canada under the code EQX, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Equinox Gold Corp (EQX) trades on the Toronto Exchange in Canada. It last closed at CAD 15.65 on 19 October 2026.
Its price-based Market X-Ray is 38 out of 100 (a weak price profile), ranking 627 of 868 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.2% and over the last three months it rose 29.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 25 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.7% | ||
| From 52-week high | -38.7% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 29.6% | ||
| 6-month return | -26.5% | ||
| 12-month return, skipping the last month | -4.1% | ||
| Stability (higher is calmer) | 22 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 62.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -52.7% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 68.96M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 5 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 1 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.1% |
|---|---|
| 1 month | −8.4% |
| 3 months | +29.6% |
| 6 months | −26.5% |
| 1 year | −12.2% |
| 3 years | +161.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 16.78 / 17.92 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Aug 2026 | CAD 0.0310 |
| 21 May 2026 | CAD 0.0210 |
| 12 Mar 2026 | CAD 0.0200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.